R2 REVLIMID/RITUXIMAB
Live / Registered — Registered (as of 09 Jun 2020)
What this means for you
Registered since 09 Jun 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88655362
- Registration number
- 6073615
- Mark type
- Design + words
- Filed
- 15 Oct 2019
- Published for opposition
- 24 Mar 2020
- Registered
- 09 Jun 2020
- Attorney of record
- Marilyn F. Kelly
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of certain cancers; pharmaceutical preparations for the treatment of lymphoma; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system; all the aforementioned goods being comprised in part of rituximab
- Class 044 — Medical, beauty and agricultural services: Medical information and counseling in the field of pharmaceuticals and safety issues pertaining to pharmaceuticals, and providing medical information in the aforementioned fields by distributing written materials in connection therewith; programs in the nature of providing medical information and counseling in the field of lenalidomide and rituximab and safety issues pertaining to lenalidomide and rituximab, and providing medical information in the aforementioned fields by distributing written materials in connection therewith; providing a web site featuring medical information; providing an internet website for medical professionals and medical patients featuring medical information; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; providing pharmaceutical advice; providing medical information, consultancy and advisory services; all the aforementioned services relating to rituximab
Owner
- Celgene Corporation, Summit, NJ, US
- Celgene Corporation, Summit, NJ, US
- Celgene Corporation, Summit, NJ, US
Prior registrations
Prosecution history
- 09 Jun 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 09 Dec 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 09 Dec 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 09 Dec 2022 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 09 Dec 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 09 Dec 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 09 Dec 2022 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 09 Jun 2020 — REGISTERED-PRINCIPAL REGISTER
- 24 Mar 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Mar 2020 — PUBLISHED FOR OPPOSITION
- 04 Mar 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 17 Feb 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 17 Feb 2020 — EXAMINER'S AMENDMENT ENTERED
- 17 Feb 2020 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 17 Feb 2020 — EXAMINERS AMENDMENT E-MAILED